Menu
Sign In Search Podcasts Charts People & Topics Add Podcast API Pricing
Podcast Image

Connect My Brain

173. The Acetaminophen-Glutathione-Autism Connection Explained | Truth Bombs

16 Oct 2025

Description

👉 Download the Connect My Brain app on Apple or Google Play! (it's free) Acetaminophen disrupts glutathione, our body's master antioxidant. Despite this, it's routinely recommended for pregnant women and children. Recent discussions have highlighted links between acetaminophen and autism—information that's actually been available for decades, yet it's only now entering mainstream conversation. This pattern isn't new. Remember red dye 40? Information about its potential to cause cancer existed for over 30 years before action was taken. We're seeing the same delay with acetaminophen and a number of other substances our families are exposed to daily. This isn't about telling anyone what to do. At Connect My Brain, we believe in personal choice and bodily autonomy. What I'm advocating for is your right to have complete information. Whether it's acetaminophen, vaccines, food additives, or any health intervention—you deserve to know what's inside, what the research shows, and what the potential risks are. Book a FREE call with Dr. Laura Enroll in the CMB Membership Learn more about Monthly Coaching Subscribe to the Connect My Brain YouTube Channel! SHOW NOTES: https://connectmybrain.com/episode173 Have a question you want answered on the podcast? Ask Dr. Laura here: https://www.connectmybrain.com/survey/ Phone the office: 678-501-5172 ** Want help starting or managing your own podcast? Talk to my producer, Marcie Paige. You focus on delivering great content—she'll take care of everything else! Visit https://marciepaige.com

Audio
Featured in this Episode

No persons identified in this episode.

Transcription

This episode hasn't been transcribed yet

Help us prioritize this episode for transcription by upvoting it.

0 upvotes
🗳️ Sign in to Upvote

Popular episodes get transcribed faster

Comments

There are no comments yet.

Please log in to write the first comment.